Huidrom Jyotsna Devi*

Department of Obstetrics and Gynaecology, Sree Balaji Medical College and Hospital, Chennai

*Corresponding Author: Huidrom Jyotsna Devi, Department of Pathology, Sree Balaji Medical College and Hospital Chennai.

Received: March 24, 2018; Published: May 28, 2018

Citation: Huidrom Jyotsna Devi. “A Study of CD10 - A Stromal Marker in Breast Carcinoma”. Acta Scientific Medical Sciences 2.3 (2018).

Abstract

  Breast carcinoma is one of the commonest cancer in women. It is the leading cause of death in women, with more than one million cases occurring worldwide annually [1]. Breast cancer represent an important public health issue, having a high occurence world- wide, with an obvious increasing tendency [2].

  Breast cancer is the most common cancer among women in India according to National cancer registry programme 2011 report [3].

1. To study the expression of CD-10 a stromal marker in breast carcinoma. 2. To study the correlation of CD10 with ER, PR and HER2/neu status in breast carcinoma.

  With the approval of the Ethical committee, SBMCH (Sree Balaji Medical college and Hospital), the study was conducted in the Department of Pathology, for the duration of two years from September 2015 to September 2017. This is a prospective study in which 50 samples of breast carcinoma by clinical and histomorphological method are included in the study.

Keywords: Stromal; Breast Carcinoma; CD10

Copyright: © 2018 Huidrom Jyotsna Devi . This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.